206 related articles for article (PubMed ID: 37576962)
21. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer.
Wang TS; Cheung K; Farrokhyar F; Roman SA; Sosa JA
Ann Surg Oncol; 2013 Oct; 20(11):3477-83. PubMed ID: 23846784
[TBL] [Abstract][Full Text] [Related]
22. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
Hall CM; LaSeur DC; Snyder SK; Lairmore TC
Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
[TBL] [Abstract][Full Text] [Related]
23. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.
Henry JF; Gramatica L; Denizot A; Kvachenyuk A; Puccini M; Defechereux T
Langenbecks Arch Surg; 1998 Apr; 383(2):167-9. PubMed ID: 9641892
[TBL] [Abstract][Full Text] [Related]
24. Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature.
Liang J; Li Z; Fang F; Yu T; Li S
Acta Otorhinolaryngol Ital; 2017 Feb; 37(1):1-8. PubMed ID: 28374865
[TBL] [Abstract][Full Text] [Related]
25. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
26. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
27. A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.
Sippel RS; Robbins SE; Poehls JL; Pitt SC; Chen H; Leverson G; Long KL; Schneider DF; Connor NP
Ann Surg; 2020 Sep; 272(3):496-503. PubMed ID: 33759836
[TBL] [Abstract][Full Text] [Related]
28. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
Giordano D; Valcavi R; Thompson GB; Pedroni C; Renna L; Gradoni P; Barbieri V
Thyroid; 2012 Sep; 22(9):911-7. PubMed ID: 22827494
[TBL] [Abstract][Full Text] [Related]
29. Level VII is an important component of central neck dissection for papillary thyroid cancer.
Wang LY; Versnick MA; Gill AJ; Lee JC; Sidhu SB; Sywak MS; Delbridge LW
Ann Surg Oncol; 2013 Jul; 20(7):2261-5. PubMed ID: 23361896
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors and pattern of locoregional recurrence after prophylactic central neck dissection in papillary thyroid carcinoma.
Lang BH; Chan DT; Wong KP; Wong KK; Wan KY
Ann Surg Oncol; 2014 Dec; 21(13):4181-7. PubMed ID: 24990632
[TBL] [Abstract][Full Text] [Related]
31. Local lymph node recurrence after central neck dissection in papillary thyroid cancers: A meta analysis.
Liu H; Li Y; Mao Y
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Nov; 136(6):481-487. PubMed ID: 31196800
[TBL] [Abstract][Full Text] [Related]
32. Clinical Efficacy of Intraoperative Ultrasound for Prophylactic Lymphadenectomy of the Lateral Cervical Neck in Stage CN0 Papillary Thyroid Cancer: A Prospective Study.
Shen Y; Li X; Tao L; Chen Y; Xie R
J Invest Surg; 2023 Dec; 36(1):2154416. PubMed ID: 36519315
[No Abstract] [Full Text] [Related]
33. [Meta-analysis of the influence of prophylactic central lymph node dissection on the prognosis of patients with thyroid micropapillary carcinoma].
An X; Yu D; Li B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):138-142. PubMed ID: 30808139
[No Abstract] [Full Text] [Related]
34. Clinical analysis of prophylactic central neck dissection for papillary thyroid carcinoma.
Wang Q; Chu B; Zhu J; Zhang S; Liu Y; Zhuang M; Yang Y
Clin Transl Oncol; 2014 Jan; 16(1):44-8. PubMed ID: 23606353
[TBL] [Abstract][Full Text] [Related]
35. Extent of thyroid surgery for clinically node-negative papillary thyroid carcinoma with confirmed nodal metastases after prophylactic central neck dissection: a 15-year experience in a single center.
Jo YJ; Choi HR; Park SH; Jeong YJ
Ann Surg Treat Res; 2020 Oct; 99(4):197-204. PubMed ID: 33029478
[TBL] [Abstract][Full Text] [Related]
36. Surgical approach to level VI in papillary thyroid carcinoma: an overview.
De Crea C; Raffaelli M; Sessa L; Lombardi CP; Bellantone R
Updates Surg; 2017 Jun; 69(2):205-209. PubMed ID: 28612210
[TBL] [Abstract][Full Text] [Related]
37. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
Barczyński M; Konturek A; Stopa M; Nowak W
Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma.
Kim BY; Choi N; Kim SW; Jeong HS; Chung MK; Son YI
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):569-576. PubMed ID: 31664515
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China.
Xue S; Wang P; Liu J; Li R; Zhang L; Chen G
Asian J Surg; 2016 Jul; 39(3):131-6. PubMed ID: 26117203
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
